» Articles » PMID: 34884985

The MiR-200 Family of MicroRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Dec 10
PMID 34884985
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The miR-200 family of microRNAs (miRNAs) includes miR-200a, miR-200b, miR-200c, miR-141 and miR-429, five evolutionarily conserved miRNAs that are encoded in two clusters of hairpin precursors located on human chromosome 1 (miR-200b, miR-200a and miR-429) and chromosome 12 (miR-200c and miR-141). The mature -3p products of the precursors are abundantly expressed in epithelial cells, where they contribute to maintaining the epithelial phenotype by repressing expression of factors that favor the process of epithelial-to-mesenchymal transition (EMT), a key hallmark of oncogenic transformation. Extensive studies of the expression and interactions of these miRNAs with cell signaling pathways indicate that they can exert both tumor suppressor- and pro-metastatic functions, and may serve as biomarkers of epithelial cancers. This review provides a summary of the role of miR-200 family members in EMT, factors that regulate their expression, and important targets for miR-200-mediated repression that are involved in EMT. The second part of the review discusses the potential utility of circulating miR-200 family members as diagnostic/prognostic biomarkers for breast, colorectal, lung, ovarian, prostate and bladder cancers.

Citing Articles

Impact of UV-Irradiated Mesoporous Titania Nanoparticles (mTiNPs) on Key Onco- and Tumor Suppressor microRNAs of PC3 Prostate Cancer Cells.

Mendez-Garcia A, Bravo-Vazquez L, Sahare P, Paul S Genes (Basel). 2025; 16(2).

PMID: 40004477 PMC: 11855573. DOI: 10.3390/genes16020148.


The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

Dieli R, Lioy R, Crispo F, Cascelli N, Martinelli M, Lerose R Biomolecules. 2025; 15(2).

PMID: 40001578 PMC: 11853026. DOI: 10.3390/biom15020275.


ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition.

Zhao S, Chen M, Chen F, Gao Z, Li X, Hu L iScience. 2025; 28(2):111819.

PMID: 39995876 PMC: 11849663. DOI: 10.1016/j.isci.2025.111819.


Effect of microRNA-141-3p, E2F3, CDK3, and KAT2B overexpression on histologic tumor grade and metastasis status in untreated breast cancer tissues.

Ebrahimian Vargahan S, Barati M, Roudbari M, Eini M, Hosseini A Bioimpacts. 2025; 15:30032.

PMID: 39963567 PMC: 11830142. DOI: 10.34172/bi.30032.


Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications.

Kishta M, Khamis A, Am H, Elshaar A, Gul D Transl Oncol. 2024; 51:102216.

PMID: 39615277 PMC: 11647223. DOI: 10.1016/j.tranon.2024.102216.


References
1.
Kim E, Kim J, Lee S, Lee H, Yoon J, Hong J . QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth. Int J Cancer. 2019; 145(6):1585-1595. DOI: 10.1002/ijc.32372. View

2.
Enkhbaatar Z, Terashima M, Oktyabri D, Tange S, Ishimura A, Yano S . KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family. Cell Cycle. 2013; 12(13):2100-12. PMC: 3737312. DOI: 10.4161/cc.25142. View

3.
Shelton P, Duran A, Nakanishi Y, Reina-Campos M, Kasashima H, Llado V . The Secretion of miR-200s by a PKCζ/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer. Cell Rep. 2018; 23(4):1178-1191. PMC: 5958623. DOI: 10.1016/j.celrep.2018.03.118. View

4.
Li J, Tan Q, Yan M, Liu L, Lin H, Zhao F . miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. Mol Cancer. 2014; 13:166. PMC: 4105889. DOI: 10.1186/1476-4598-13-166. View

5.
Debeb B, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A . miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst. 2016; 108(8). PMC: 5017951. DOI: 10.1093/jnci/djw026. View